Here’s what you should know.
1. The DiLumen EIP ensures complete positioning of an endoscope in the large intestine to assist with visualization, diagnosis and endoscopic treatment.
2. The device can improve endolumenal treatments, which may allow for less invasive procedures taking the place of laparoscopic surgery.
3. Lumendi is in the process of conducting a post-market outcome study. The FDA awarded the DiLumen FDA 510(k) clearance in December 2016.
More articles on gastroenterology:
IBS-D puts financial strain on patients: 4 study insights
CMS announces new Crohn’s Disease code after AGA, ACG petition — 4 insights
Gastro Health acquires Dr. Orlando Torres’ practice: 3 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
